(Reuters Health)—Media reports raising safety concerns about osteoporosis drugs known as bisphosphonates may have contributed to a sharp drop in their use—even though U.S. doctors and drug regulators haven’t recommended against taking them, a study suggests. Fosamax (alendronate sodium) won U.S. marketing approval in 1995. Widespread use of the drug and others like it over…
Search results for: iPhone
Tips for Treating Insomnia in Rheumatology Patients
Chronic insomnia is a common complaint for patients with rheumatic diseases and conditions. In fact, sleep disturbances are among the most common symptoms of both fibromyalgia and rheumatoid arthritis (RA), with more than 50% of chronic pain patients reporting sleep disturbances. Pain combined with insomnia can lead to a vicious cycle, says Ruth Gentry, PhD,…
HealthKit Wellness App Holds Promise for Medicine, Rheumatology
Apple’s mobile healthcare technology may benefit patients with rheumatic disease whose conditions require regular monitoring
Personal Health Records Bring Benefits, Limitations to Rheumatology Patient Care
PHRs offer time-saving, communication perks for patients and physicians, but may pose health literacy challenges
Expansion of Mobile Health Apps Makes Physicians’ Job Easier
Rheumatologists choose, review top mobile health devices
Rheuminations: How Disruptive Technology Has Transformed the Medical School Classroom
iPads, social media, and massive, open online classes have changed the way we teach
How the Mayo Clinic Maximizes Learning Opportunities Through Social Media
The Mayo Clinic’s Center for Social Media has become a social media resource for healthcare providers nationwide
Tech Talk: Apps Put More Rheumatology Information at Fingertips
With more and more mobile devices and apps coming onto the market, more and more information is available to rheumatologists on the go.
New Year, New Faces
The Rheumatologist welcomes new editorial team
Rheum With a View
Panush’s perspectives on selections from the literature